Jacques Rachelle Suzanne
Insider CIK 1772610 · AKTX Chief Executive Officer, Director · QURE Director · CRBP Director · VIE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QURE uniQure N.V. | S Sale | 2026-06-11 | 2026-06-12 | 1,993 | $27.06 | $53.9K | 33,903 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2026-06-10 | 2026-06-12 | 13,980 | — | $0 | 13,980 | SEC↗ |
| QURE uniQure N.V. | A Award | 2026-06-10 | 2026-06-12 | 7,550 | — | $0 | 35,896 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2026-05-19 | 2026-05-21 | 12,300 | — | $0 | 12,300 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2026-05-19 | 2026-05-21 | 3,800 | — | $0 | 11,383 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2025-06-20 | 2025-06-24 | 2,112 | $14.45 | $30.5K | 28,346 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2025-06-11 | 2025-06-13 | 15,630 | — | $0 | 15,630 | SEC↗ |
| QURE uniQure N.V. | A Award | 2025-06-11 | 2025-06-13 | 7,970 | — | $0 | 30,458 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 7,583 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2024-06-19 | 2024-06-21 | 15,840 | — | $0 | 15,840 | SEC↗ |
| QURE uniQure N.V. | A Award | 2024-06-19 | 2024-06-21 | 8,080 | — | $0 | 22,488 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2024-06-13 | 2024-06-17 | 2,221 | $5.14 | $11.4K | 14,408 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 2,783 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-04-26 | 2024-04-30 | 479,569,892 | — | $0 | 1,018,027,792 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2023-06-16 | 2023-06-20 | 2,301 | $18.76 | $43.2K | 16,629 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2023-06-13 | 2023-06-20 | 17,060 | — | $0 | 17,060 | SEC↗ |
| QURE uniQure N.V. | A Award | 2023-06-13 | 2023-06-20 | 8,700 | — | $0 | 18,930 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2023-02-27 | 2023-03-01 | 384 | $20.02 | $7.7K | 10,230 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2022-06-15 | 2022-06-17 | 17,810 | — | $0 | 17,810 | SEC↗ |
| QURE uniQure N.V. | A Award | 2022-06-15 | 2022-06-17 | 9,080 | — | $0 | 10,614 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2022-05-18 | 2022-05-19 | 79,600 | — | $0 | 79,600 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2022-02-24 | 2022-02-28 | 2,645 | — | $0 | 2,645 | SEC↗ |
| QURE uniQure N.V. | A Award | 2022-02-24 | 2022-02-28 | 1,534 | — | $0 | 1,534 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2021-10-21 | 2021-10-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2021-06-17 | 2021-06-17 | 58,200 | — | $0 | 58,200 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 7,358 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 14,716 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | A Award deriv | 2020-06-19 | 2020-06-23 | 14,716 | — | $0 | 14,716 | SEC↗ |
| VIE Viela Bio, Inc. | A Award deriv | 2020-06-19 | 2020-06-24 | 14,716 | — | $0 | 14,716 | SEC↗ |
| VIE Viela Bio, Inc. | A Award deriv | 2020-06-19 | 2020-06-24 | 7,358 | — | $0 | 7,358 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2020-05-20 | 2020-05-22 | 40,500 | — | $0 | 40,500 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2019-05-22 | 2019-06-28 | 33,300 | — | $0 | 33,300 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2019-04-05 | 2019-04-08 | 68,000 | — | $0 | 68,000 | SEC↗ |